|
NewswireTODAY - /newswire/ -
Albuquerque, NM, United States, 2013/07/22 - Working in her new capacity in OsoBio's Philadelphia location, Pruitt will identify and foster new business opportunities throughout the Northeast - OsoBio.com.
|
|
|
|
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements
Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!
|
|
OsoBio has named Lindsey Pruitt manager of new business development for its East Coast market.
Working in her new capacity in OsoBio’s Philadelphia location, Pruitt will identify and foster new business opportunities throughout the Northeast.
Pruitt has worked nearly a decade in sales and marketing within the pharmaceutical and specialty chemical manufacturing industries.
Most recently, she served as manager of commercial operations and sales for Siegfried USA, a manufacturer of active pharmaceutical ingredients (APIs). There, she was responsible for managing key accounts and serving as the primary customer contact from research and development to commercial product launch.
“Lindsey shows a real passion for working in partnership with OsoBio’s clients to deliver life-saving pharmaceuticals to the patients who need them,” said Milton Boyer, president of OsoBio. “She will demonstrate for clients the value OsoBio can bring as the contract manufacturer of choice for their sterile injectable needs.”
Pruitt graduated cum laude from Lee University with a bachelor’s degree in psychology and advanced studies in microbiology and chemistry.
OSO BioPharmaceuticals Manufacturing, LLC (osobio.com), is a contract manufacturing organization (CMO) that specializes in delivering injectable sterile liquid, suspension and lyophilized biologic and pharmaceutical products to the pharmaceutical industry. Our company offers significant knowledge and experience in late-phase clinical products and successfully taking them to commercialization.
In the history of our Albuquerque, N.M., facility, OsoBio has manufactured more than 250 distinct commercial presentations in every major therapeutic category. The U.S. Drug Enforcement Administration (DEA) has granted OsoBio registrations for Schedule II through V controlled substances.
OsoBio surpasses quality-assurance expectations within our industry. Our employees are industry veterans who provide innovative solutions to our clients’ most difficult projects.
|
|
|
|
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements
Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!
|
|
Agency / Source: Sinclair & Co.
|
|
|
|
Availability: All Regions (Including Int'l)
|
|
Traffic Booster: [/] Quick NewswireToday Visibility Checker
|
|
Distribution / Indexing: [+]
|
|
|
|
# # #
|
|
|
|
|
|
Your Banner Ad showing on ALL Pharma / BioTech / Nutrition articles, CATCH Visitors via Your Competitors Announcements!
Company website links NOT available to basic submissions |
|
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source. |
|
|
|
For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
| |
Contact: Karen Stinneford - Sinclair-Co.com
919-833-9102 kys[.]sinclair-co.com
|